TABLE 4

Comparison of reversible IC50 values generated from the reversible P450 inhibition screen ( Weaver et al., 2003 ) for sulfaphenazole (SPZ), quinidine (QUI), and ketoconazole (KCZ) and those projected from a single inhibitor concentration in the human liver microsomal, single-time point time-dependent inhibition assay

R + INADPH is the rate of P450 probe reaction when the initial (pre-) incubation is performed in the presence of inhibitor and NADPH. RINADPH is the rate of P450 probe reaction when the initial (pre-) incubation is performed in the absence of inhibitor (i.e., solvent control) but the presence of NADPH. R + INO NADPH is the rate of P450 probe reaction when the initial (pre-) incubation is performed in the presence of inhibitor but the absence of NADPH.




R + INADPH/R - INADPH

R + INO NADPH/R - INO NADPH

Percentage TDIa

Projected Reversible IC50b

IC50c
μM μM
1 μM SPZ 0.61 0.59 -4.5 0.14 0.2
10 μM SPZ 0.19 0.18 -5.1 0.13 0.2
25 nM QUI 0.81 0.83 1.9 0.013 0.015
250 nM QUI 0.49 0.54 8.2 0.022 0.015
5 nM KCZ 0.97 0.92 -5 0.005 0.005
50 nM KCZ
0.87
0.8
-8
0.028
0.005
  • a Percentage TDI was calculated according to eq. 2 (Results). Values are the average of duplicate incubations performed within a single experiment.

  • b Projected reversible IC50 was calculated according to eqs. 3 to 5 (Results). Values are the average of duplicate incubations performed within a single experiment.

  • c Reversible IC50 values were generated from the reversible P450 inhibition screen (set up as described in Weaver et al., 2003). Values are the mean of 150 replicates.